Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 354 participants.

Also called NCT05940597

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 354 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05940597
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05940597. Randomized; no masking; primary purpose treatment. Start 2023-09-25 (actual); primary completion 2026-03-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
Acronym
FACIL AF
Condition
Atrial Fibrillation Paroxysmal
Intervention (Device)
Pulse field ablation
Intervention (Device)
Cryoballoon pulmonary vein isolation
Lead sponsor
University Hospital, Grenoble (class: other)
Collaborator
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct05940597
Content hash
164ce30c2314f82e6f1daac858d4aa8c1c1fdfd29245d9f7e46df63e300a9c08